Founded in January of 2020, VREX Therapeutics is built upon the ground-breaking science of Prof. Dr. Feng Yao, out of Harvard Medical School and Brigham and Women's Hospital. VREX Therapeutics is driven to create new immunotherapy drugs that assist in treating and curing solid tumor cancers.